National Cancer Institute; Cancellation of Meeting
---
identifier: "/us/fr/2012-6596"
source: "fr"
legal_status: "authoritative_unofficial"
title: "National Cancer Institute; Cancellation of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2012-6596"
section_name: "National Cancer Institute; Cancellation of Meeting"
positive_law: false
currency: "2012-03-19"
last_updated: "2012-03-19"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2012-6596"
document_type: "notice"
publication_date: "2012-03-19"
agencies:
- "Health and Human Services Department"
- "National Institutes of Health"
fr_citation: "77 FR 16044"
fr_volume: 77
---
# National Cancer Institute; Cancellation of Meeting
Notice is hereby given of the cancellation of the National Cancer Institute Special Emphasis Panel, Clinical Assay Development Program (CADP), April 10, 2012, 8 a.m. to 4 p.m., National Institutes of Health, 6001 Executive Boulevard, Room C, Rockville, MD 20852 which was published in the *Federal Register* on February 29, 2012, 77 FR 12318.
The meeting has been cancelled.
Dated: March 12, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.